High Margins For Generic Cymbalta May Attract India’s Dr. Reddy’s For A Late Launch
This article was originally published in PharmAsia News
Executive Summary
Limited competition and better-than-expected pricing for generic versions of Eli Lilly’s depression drug Cymbalta may drive Dr. Reddy’s to launch the product in the United States.